Milestone Pharmaceuticals Inc. Common Shares
MIST
MIST: Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT.
moreShow MIST Financials
Recent trades of MIST by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by MIST's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on MIST's company Twitter account
Number of mentions of MIST in WallStreetBets Daily Discussion
Recent insights relating to MIST
Recent picks made for MIST stock on CNBC
ETFs with the largest estimated holdings in MIST
Flights by private jets registered to MIST